Free Standard Shipping on orders over $100
PepVial
Retatrutide - Image 1

Retatrutide

Triple Receptor Agonist

Research Use Only
4.8(4 reviews)
€209.99
Size
Qty
1
In Stock
Retatrutide—
€209.99

Retatrutide (LY-3437943) is a novel triple agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. This investigational compound represents a new class of multi-receptor agonist peptides being studied for metabolic research applications.

Key Features:

  • High purity (≥ 99.6%)
  • White lyophilized powder
  • Triple receptor activity (GIP/GLP-1/Glucagon)
  • Novel research compound

Research Applications:

  • Metabolic regulation studies
  • Receptor binding and activation research
  • Energy homeostasis studies
  • Incretin pathway research
Research Grade≥99.6% Purity
COA IncludedEvery Order
Discreet ShippingPlain Packaging

Customer Reviews

4.8
4 reviews
5★
3
4★
1
3★
0
2★
0
1★
0
February 12, 2026Verified Purchase

Outstanding quality for our obesity research applications. The triple receptor agonist properties are well-preserved in this formulation.

January 28, 2026Verified Purchase

Good product for GLP-1 research. Arrived well-packaged and the COA documentation is comprehensive. Looking forward to ordering more.

January 3, 2026Verified Purchase

High purity Retatrutide. Our metabolic research team is impressed with the quality. The tri-agonist peptide is well-synthesized and stable.

December 10, 2025Verified Purchase

Excellent Retatrutide for our triple agonist research. The GLP-1/GIP/glucagon receptor binding studies show clean results with this product.

Sign in to leave a review.

Related products

You might also want to check out these products.